A Study to Assess the Efficacy and Safety of VK2809 for 52 Weeks in Subjects With Biopsy Proven NASH
Trial details
- Registry ID
- NCT04173065
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study to Assess the Efficacy and Safety of VK2809 for 52 Weeks in Subjects With Biopsy Proven NASHNCT04173065 | VKTX | Phase 2 | Completed | 2023-05-15Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |